Nestle Shouldn't Face 3D Facial Injection IP Suit, Judge Says

By Tiffany Hu · December 16, 2019, 5:45 PM EST

Nestle may escape accusations that its skin care unit infringed a company's patented technology for teaching professionals how to safely inject Botox and dermal fillers after a Delaware federal judge recommended...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Truinject Corp. v. Galderma S.A., et al

Case Number

1:19-cv-00592

Court

Delaware

Nature of Suit

Patent

Date Filed

March 28, 2019